GHK-Cu (glycine-L-histidine-L-lysine copper complex) is a naturally occurring tripeptide-copper complex with a biological history extending back to its initial identification in human plasma by Loren Pickart in 1973. Over five decades of research have characterized it as a pleiotropic modulator of tissue remodeling, gene expression, and cellular repair processes.
Discovery and Natural Biology
GHK was first isolated from human plasma albumin and identified as a factor that stimulated liver tissue regeneration. Subsequent research identified its copper-binding capacity and demonstrated that the GHK-Cu complex — rather than the unbound peptide — is the biologically active form.
Plasma GHK-Cu concentrations are highest in young adults (approximately 200ng/mL) and decline with age, falling to approximately 80ng/mL by age 60. This age-related decline has been proposed as a contributing factor to reduced tissue regenerative capacity in aging.
Gene Expression Research
Among GHK-Cu's most significant research findings is its capacity to broadly modulate gene expression. Microarray analysis of human fibroblasts treated with GHK-Cu documented regulation of over 4,000 genes — approximately one-third of the human genome — including genes involved in collagen synthesis, anti-inflammatory signaling, antioxidant defense, DNA repair, and stem cell biology.
This breadth of gene regulatory activity distinguishes GHK-Cu from more narrowly targeted research compounds and makes it relevant to a wide range of tissue biology research applications.
Wound Healing Research
The most extensively documented effects of GHK-Cu are in wound healing models. Research has demonstrated stimulation of fibroblast proliferation and migration, upregulation of collagen and glycosaminoglycan synthesis, and enhanced wound contraction in excisional wound models.
The proposed mechanisms include TGF-β upregulation (which activates fibroblasts and drives collagen production), matrix metalloproteinase modulation (which regulates extracellular matrix remodeling), and pro-angiogenic activity through VEGF stimulation.
Anti-Inflammatory Activity
GHK-Cu demonstrates anti-inflammatory effects in multiple research models. Studies have documented reduction of TNF-α expression, downregulation of inflammatory gene clusters, and modulation of NF-κB signaling — a central transcriptional regulator of inflammatory responses.
Pickart and Margolina (2018) reviewed GHK-Cu's anti-inflammatory activity, noting its capacity to simultaneously upregulate tissue-protective genes while downregulating inflammatory and damage-response pathways.
Nervous System Research
Research examining GHK-Cu's effects in neurological models has documented neuroprotective effects in oxidative stress paradigms, stimulation of nerve growth factor expression, and effects on neuronal gene expression profiles relevant to neurodegenerative research.
Skin Biology Research
GHK-Cu has been extensively studied in dermatological research models, where its effects on dermal fibroblast activity, collagen architecture, and barrier function have been characterized. This body of research has driven its application in cosmetic formulations, though its use in research contexts is distinct from cosmetic application.